NCT04179474 Safety, Tolerability and Drug- Drug Interaction Study of Ubrogepant With Erenumab or Galcanezumab in Participants With Migraine Status COMPLETED Phase PHASE1
NCT04171362 The Effect of Connective Tissue Massage in Patients With Migraine Status COMPLETED Phase NA
NCT04163185 Initiating Early Control of Migraine Pain and Associated Symptoms Status COMPLETED Phase PHASE3
NCT04152083 A Study to Evaluate the Efficacy and Safety of Eptinezumab Administered Intravenously in Participants Experiencing Acute Attack of Migraine Status COMPLETED Phase PHASE3
NCT04138316 CandeSpartan Study. Candesartan Spanish Response-prediction and Tolerability Study Status COMPLETED Phase N/A
NCT04114630 Study of Quality of Life in Subjects With Chronic or High-frequency Episodic Migraine and Associated Comorbidities Treated With Erenumab Status WITHDRAWN Phase PHASE3
NCT04104399 Single Ascending Dose Study to Investigate the Safety and Pharmacokinetics of XC101-D13H in Healthy Adult Subjects Status UNKNOWN Phase PHASE1
NCT04090333 Endocrinological Profile in Patients With Medication-overuse Headache Before and After Withdrawal Therapy Status COMPLETED Phase N/A
NCT04084314 Assessment of Prolonged Safety and tOLerability of in Migraine Patients in a Long-term OpeN-label Study Status COMPLETED Phase PHASE4
NCT04068051 Multimechanistic Treatment Over Time of Migraine Symptoms (MOVEMENT) Status COMPLETED Phase PHASE3
NCT04041284 A Study to Evaluate the Efficacy and Safety of Fremanezumab for Preventive Treatment of Migraine in Patients With Major Depressive Disorder Status COMPLETED Phase PHASE4
NCT04031469 A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease Status SUSPENDED Phase N/A
NCT04012593 Diary-based Study on the Course of Hormone-withdrawal Migraines Status COMPLETED Phase N/A
NCT04012047 Headache Inducing Effect of Levcromakalim in Migraine With Aura Patients Status COMPLETED Phase NA